ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Lansoprazol Sandoz 15 mg, magensaftresistente Hartkapseln - 14 Kapsel(n)
58131022 Sandoz Pharmaceuticals AG
Lansoprazol Sandoz 15 mg, magensaftresistente Hartkapseln30.04.2008
  30.04.2008
Lansoprazole (A02BC03) 
WHO-DDD 
04.99.14 Kapsel(n)
04.99. 
B  
No 
IPCI
   
k.A. 
  
7680581310229Synthetika
  
Composition
lansoprazolum 15 mg, sacchari sphaerae cum saccharum max. 69.6 mg et maydis amylum, hypromellosum, talcum, E 171, magnesii subcarbonas levis, acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum, natrii laurilsulfas, polysorbatum 80, macrogolum 400, silica colloidalis anhydrica, carrageenanum, kalii chloridum, pro capsula corresp. natrium 0.009 mg.
Packungsbestandteile
magensaftresistente Hartkapseln 
  
 
Active AgentDose
Lansoprazole15 mg
BAG: Active AgentDose
Lansoprazole15 mg
 
Inactive agentsDoseadditional_information
Acidi Methacrylici  
Carrageenanum  
E 171 color.
Ethylis Acrylatis Polymerisatum Dispersio30  
Hypromellosum  
Potassium Chloride  
Macrogol400  
Magnesii Subcarbonas Levis  
Maydis Amylum  
Natrii Laurilsulfas  
Per Centum  
Polysorbatum 80  
Sacchari Sphaerae cum Saccharum69.6 mg 
Silica Colloidalis Anhydrica  
Talcum  
 
Source
Data was imported : 15.12.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | Login | Contact | Home